Open access · US-GOV via ClinicalTrials.gov Clinical trial

The Safety and Effectivness of Quercetin and Dasatinib on the Epigenetic Aging Rates in Healthy Individuals

Authors not listed

TruDiagnostic · 2020

Epigenetic alterations Senolytics Human Randomized controlled trial

Abstract

Assessing the effects of Quercitin and Dasatinib over a 16 week period on participatns' epigenetic biological aging. The patients are being tested at baseline, halfway point, and after the trial period.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-10 MST

Cite this

APA

Anonymous. (2020). The Safety and Effectivness of Quercetin and Dasatinib on the Epigenetic Aging Rates in Healthy Individuals. <em>TruDiagnostic</em>. https://clinicaltrials.gov/study/NCT04946383

Vancouver

Anonymous. The Safety and Effectivness of Quercetin and Dasatinib on the Epigenetic Aging Rates in Healthy Individuals. TruDiagnostic. 2020.

BibTeX

@misc{anon2020TheSaf, title = {The Safety and Effectivness of Quercetin and Dasatinib on the Epigenetic Aging Rates in Healthy Individuals}, author = {Anonymous}, journal = {TruDiagnostic}, year = {2020}, }